CLOs on the Move


 
WeedMD Inc. is the publicly-traded parent company of WeedMD RX Inc. and Starseed Medicinal Inc., federally-licensed producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as CX Industries Inc., a wholly-owned subsidiary which specializes in cannabis extraction from the Company`s fully-licensed 26,000 sq. ft. Aylmer, Ontario processing facility. With the addition of Starseed, a medical-centric operator based in Bowmanville, Ontario, WeedMD has expanded its multi-channeled distribution strategy. Starseed`s industry-first, exclusive partnership with LiUNA, the largest construction union in Canada, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.weedmd.com
  • 250 Elm Street
    Aylmer, ON CAN N5H 2M8
  • Phone: 844.933.3636

Executives

Name Title Contact Details

Similar Companies

Sinaiko Healthcare Consulting

Sinaiko Healthcare Consulting is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Inner Dimension TV

Inner Dimension TV is a monthly subscription platform full of high-quality cinematic yoga and meditation classes. Start your 10-day free trial today.

Systagenix Wound Management (US)

Systagenix Wound Management (US) is a Quincy, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Stilla Technologies

Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla`s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the world`s first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics.

PT Plus

Providing cutting edge therapeutic solutions to you, your family and friends.